» Articles » PMID: 1463587

Thymopoietin, a Thymic Polypeptide, Potently Interacts at Muscle and Neuronal Nicotinic Alpha-bungarotoxin Receptors

Overview
Journal Mol Neurobiol
Date 1992 Jan 1
PMID 1463587
Authors
Affiliations
Soon will be listed here.
Abstract

Current studies suggest that several distinct populations of nicotinic acetylcholine (ACh) receptors exist. One of these is the muscle-type nicotinic receptors with which neuromuscular nicotinic receptor ligands and the snake toxin alpha-bungarotoxin interact. alpha-Bungarotoxin potently binds to these nicotinic receptors and blocks their function, two characteristics that have made the alpha-toxin a very useful probe for the characterization of these sites. In neuronal tissues, several populations of nicotinic receptors have been identified which, although they share a nicotinic pharmacology, have unique characteristics. The alpha-bungarotoxin-insensitive neuronal nicotinic receptors, which may be involved in mediating neuronal excitability, bind nicotinic agonists with high affinity but do not interact with alpha-bungarotoxin. Subtypes of these alpha-toxin-insensitive receptors appear to exist, as evidenced by findings that some are inhibited by neuronal bungarotoxin whereas others are not. In addition to the alpha-bungarotoxin-insensitive sites, alpha-bungarotoxin-sensitive neuronal nicotinic receptors are also present in neuronal tissues. These latter receptors bind alpha-bungarotoxin with high affinity and nicotinic agonists with an affinity in the microM range. The function of the nicotinic alpha-bungarotoxin receptors are as yet uncertain. Thymopoietin, a polypeptide linked to immune function, appears to interact specifically with nicotinic receptor populations that bind alpha-bungarotoxin. Thus, in muscle tissue where alpha-bungarotoxin both binds to the receptor and blocks activity, thymopoietin also potently binds to the receptor and inhibits nicotinic receptors-mediated function. In neuronal tissues, thymopoietin interacts only with the nicotinic alpha-bungarotoxin site and not the alpha-bungarotoxin-insensitive neuronal nicotinic receptor population. These observations that thymopoietin potently and specifically interacts with nicotinic alpha-bungarotoxin-sensitive receptors in neuronal and muscle tissue, together with findings that thymopoietin is an endogenously occurring agent, could suggest that this immune-related polypeptide represents a ligand for the alpha-bungarotoxin receptors. The function of thymopoietin at the alpha-bungarotoxin receptor is as yet uncertain; however, a potential trophic, as well as other roles are suggested.

References
1.
Deneris E, Connolly J, Boulter J, Wada E, Wada K, Swanson L . Primary structure and expression of beta 2: a novel subunit of neuronal nicotinic acetylcholine receptors. Neuron. 1988; 1(1):45-54. DOI: 10.1016/0896-6273(88)90208-5. View

2.
McLane K, Wu X, Schoepfer R, Lindstrom J . Identification of sequence segments forming the alpha-bungarotoxin binding sites on two nicotinic acetylcholine receptor alpha subunits from the avian brain. J Biol Chem. 1991; 266(23):15230-9. View

3.
Deneris E, Connolly J, ROGERS S, DUVOISIN R . Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol Sci. 1991; 12(1):34-40. DOI: 10.1016/0165-6147(91)90486-c. View

4.
Loring R, Aizenman E, Lipton S, Zigmond R . Characterization of nicotinic receptors in chick retina using a snake venom neurotoxin that blocks neuronal nicotinic receptor function. J Neurosci. 1989; 9(7):2423-31. PMC: 6569765. View

5.
Luetje C, Patrick J, Seguela P . Nicotine receptors in the mammalian brain. FASEB J. 1990; 4(10):2753-60. DOI: 10.1096/fasebj.4.10.2197155. View